✦ LIBER ✦

TERT promoter mutation in resectable hepatocellular carcinomas: A strong association with hepatitis C infection and absence of hepatitis B infection

✍ Scribed by Chen, Yu-Ling; Jeng, Yung-Ming; Chang, Chih-Ning; Lee, Hsin-Jung; Hsu, Hey-Chi; Lai, Po-Lin; Yuan, Ray-Hwang

Book ID: 124110387
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 883 KB
Volume: 12
Category: Article
ISSN: 1743-9191
DOI: 10.1016/j.ijsu.2014.05.066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Occult hepatitis B virus infection is as

Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients

✍ Giovanni Squadrito; Teresa Pollicino; Irene Cacciola; Gaia Caccamo; Daniela Vill 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

Occult and previous hepatitis B virus in

Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C

✍ Anna S. Lok; James E. Everhart; Adrian M. Di Bisceglie; Hae-Young Kim; Munira Hu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 2 views

Previous studies have suggested that prior exposure to hepatitis B virus (HBV) infection may increase the risk of development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C. The aim of this study was to compare the prevalence of previous or occult HBV infection in a cohort of

Association of concurrent hepatitis B su

Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection

✍ Ji Sun Jang; Hyoung Su Kim; Ha Jung Kim; Woon Geon Shin; Kyung Ho Kim; Jin Heon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract Antibody to hepatitis B surface antigen (HBsAg) (anti‐HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and anti‐HBs (concurrent HBsAg/ anti‐HBs) with hepatocellular carcinoma (HCC). The aim of t

657 ASSOCIATION WITH HEPATOCELLULAR CARC

657 ASSOCIATION WITH HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS X AND CORE PROMOTER MUTATIONS AMONG PATIENTS INFECTED WITH HBV/C2 IN KOREA: A CASE CONTROL STUDY

✍ J.K. Kim; H.Y. Chang; S.H. Ahn; D.Y. Kim; Y.H. Paik; K.S. Lee; K.H. Han; C.Y. Ch 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Primary hepatic malignant lymphoma: Its

Primary hepatic malignant lymphoma: Its occurrence in a patient with chronic active hepatitis, cirrhosis, and hepatocellular carcinoma associated with hepatitis B viral infection

✍ Thomas S. Talamo; Andrew Dekker; John Gurecki; Gurmukh Singh 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 764 KB

Role of interleukin-18 and its receptor

Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection

✍ Masami Asakawa; Hiroshi Kono; Hidetake Amemiya; Masanori Matsuda; Tetsuya Suzuki 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 339 KB 👁 1 views

## Abstract Interleukin (IL)‐18 is a proinflammatory cytokine that is up‐regulated in patients with hepatitis C virus (HCV) infection, which is the most common underlying disease in hepatocellular carcinoma (HCC). The purpose of our study was to investigate the role of IL‐18 in HCC associated with